Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma

European Journal of Cancer

Volumn 44, Issue 7, 2008, Pages 1039-1047

  Perego, Roberto A ^a   Corizzato, Matteo ^a   Brambilla, Paola ^a   Ferrero, Stefano ^b   Bianchi, Cristina ^a   Fasoli, Ester ^b   Signorini, Stefano ^a   Torsello, Barbara ^a   Invernizzi, Lara ^a   Bombelli, Silvia ^a   Angeloni, Valentina ^a   Pitto, Marina ^a   Battaglia, Cristina ^c   Proserpio, Vanessa ^a   Magni, Fulvio ^a   Galasso, Giacomo ^c   Mocarelli, Paolo ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN PAOLO HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Follow up; Microsatellite LOH; Plasma DNA concentration; Renal cell carcinoma; Tumour markers

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CELL PROLIFERATION; CHROMOSOMES, HUMAN, PAIR 3; DNA, NEOPLASM; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; LOSS OF HETEROZYGOSITY; MALE; MICROCIRCULATION; MICROSATELLITE REPEATS; MIDDLE AGED; ROC CURVE;

EID: 42649132096     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2008.03.008     Document Type: Article

References (29)

1. Cohen H.T., and McGovern F.J. Renal cell carcinoma. N Engl J Med 353 (2005) 2477-2490
2. Brugarolas J. Renal cell carcinoma - molecular pathways and therapies. N Engl J Med 356 (2007) 185-187
3. Fleischhacker M., and Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 1775 (2007) 181-232
4. Gormally E., Caboux E., Vineis P., and Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635 (2007) 105-117
5. Jahr S., Hentze H., Englisch S., et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 61 (2001) 1659-1665
6. Wang B.G., Huang H.Y., Chen Y.C., et al. Increased plasma DNA integrity in cancer patients. Cancer Res 63 (2003) 3966-3968
7. Sozzi G., Conte D., Mariani L., et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 61 (2001) 4675-4678
8. Sozzi G., Conte D., Leon M., et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21 (2003) 3902-3908
9. Gormally E., Hainaut P., Caboux E., et al. Amount of DNA in plasma and cancer risk: a prospective study. Int J Cancer 111 (2004) 746-749
10. Ren N., Ye Q.H., Qin L.X., Zhang B.H., Liu Y.K., and Tang Z.Y. Circulating DNA level is negatively associated with the long-term survival of hepatocellular carcinoma patients. World J Gastroenterol 12 (2006) 3911-3914
11. Chun F.K., Muller I., Lange I., et al. Circulating tumour-associated plasma DNA represents an independent and informative predictor of prostate cancer. BJU Int 98 (2006) 544-548
12. Hanley R., Rieger-Christ K.M., Canes D., et al. DNA integrity assay: a plasma-based screening tool for the detection of prostate cancer. Clin Cancer Res 12 (2006) 4569-4574
13. Umetani N., Kim J., Hiramatsu S., et al. Increased integrity of free circulating DNA in sera of patients with colorectal or periampullary cancer: direct quantitative PCR for ALU repeats. Clin Chem 52 (2006) 1062-1069
14. Chang H.W., Lee S.M., Goodman S.N., et al. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 94 (2002) 1697-1703
15. Andriani F., Conte D., Mastrangelo T., et al. Detecting lung cancer in plasma with the use of multiple genetic markers. Int J Cancer 108 (2004) 91-96
16. Diehl F., Li M., Dressman D., et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci USA 102 (2005) 16368-16373
17. Urakami S., Shiina H., Enokida H., et al. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA. Clin Cancer Res 12 (2006) 6989-6997
18. Chudek J., Wilhelm M., Bugert P., Herbers J., and Kovacs G. Detailed microsatellite analysis of chromosome 3p region in non-papillary renal cell carcinomas. Int J Cancer 73 (1997) 225-229
19. Eble J.N., Sauter G., Epstein J.I., and Sesterhenn I.A. WHO pathology and genetics of tumours of the urinary system and male genital organs (2004), IARC Press, Lyon
20. Panteli K., Zagorianakou N., Bai M., Katsaraki A., Agnantis N.J., and Bourantas K. Angiogenesis in chronic myeloproliferative diseases detected by CD34 expression. Eur J Haematol 72 (2004) 410-415
21. Florena A.M., Tripodo C., Iannitto E., Porcasi R., Ingrao S., and Franco V. Value of bone marrow biopsy in the diagnosis of essential thrombocythemia. Haematologica 89 (2004) 911-919
22. Poncz M., Schwartz E., Ballantine M., and Surrey S. Nucleotide sequence analysis of the delta beta-globin gene region in humans. J Biol Chem 258 (1983) 11599-11609
23. Larson P.S., Schlechter B.L., de las Morenas A., Garber J.E., Cupples L.A., and Rosenberg C.L. Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissues. J Clin Oncol 23 (2005) 8613-8619
24. Sozzi G., Roz L., Conte D., et al. Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays. J Natl Cancer Inst 97 (2005) 1848-1850
25. Goessl C., Heicappell R., Münker R., et al. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma. Cancer Res 58 (1998) 4728-4732
26. Eisenberger C.F., Schoenberg M., Enger C., et al. Diagnosis of renal cancer by molecular urinalysis. J Natl Cancer Inst 91 (1999) 2028-2032
27. von Knobloch R., Hegele A., Brandt H., et al. High frequency of serum DNA alterations in renal cell carcinoma detected by fluorescent microsatellite analysis. Int J Cancer 98 (2002) 889-894
28. Gonzalgo M.L., Eisenberger C.F., Lee S.M., et al. Prognostic significance of preoperative molecular serum analysis in renal cancer. Clin Cancer Res 8 (2002) 1878-1881
29. Brüggemann M., Raff T., Flohr T., et al. Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 107 (2006) 1116-1123